Issue 2/2020
Content (23 Articles)
Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy
Richard C. Becker, A. Phillip Owens III, Sakthivel Sadayappan
The dawn of aspirin free strategy after short term dual antiplatelet for percutaneous coronary intervention: meta-analysis of randomized controlled trials
Mohammed Osman, Peter D. Farjo, Khansa Osman, Qais Radaideh, Muhammad Bilal Munir, Babikir Kheiri, Sudarshan Balla
Rationale and design of “Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)” study
Ying X. Gue, Rahim Kanji, David M. Wellsted, Manivannan Srinivasan, Solange Wyatt, Diana A. Gorog
Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin
Damon E. Houghton, Alexander Lekah, Thanila A. Macedo, David Hodge, Rayya A. Saadiq, Yvonne Little, Ana I. Casanegra, Robert D. McBane, Waldemar E. Wysokinski
Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels
Alex M. Ebied, Tammy Li, Samantha F. Axelrod, Douglas J. Tam, Yiqing Chen
Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial
Walter Ageno, Renato D. Lopes, Megan K. Yee, Adrian Hernandez, Russell Hull, Samuel Z. Goldhaber, C. Michael Gibson, Alexander T. Cohen
Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism
Ming Sheng Lim, Dee Nandurkar, Ian Jong, Anita Cummins, Huyen Tran, Sanjeev Chunilal
Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α
Anne Hollerbach, Nadine Müller-Calleja, Antje Canisius, Carolin Orning, Karl J. Lackner
Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction
Ugochukwu Shola Owolabi, Alok Ravindra Amraotkar, Amanda R. Coulter, Narayana Sarma V. Singam, Bahjat N. Aladili, Ayesha Singh, Patrick James Trainor, Riten Mitra, Andrew Paul DeFilippis
Determination of the cut-off prothrombin time to estimate plasma rivaroxaban overdose status
Bohyun Kim, Seongsoo Jang, Yu-Jin Lee, Nuree Park, Young-Uk Cho, Chan-Jeoung Park
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study
Maria Cristina Vedovati, Maria Giulia Mosconi, Federico Isidori, Giancarlo Agnelli, Cecilia Becattini
Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients
Jacob T. Beyer, Stuart E. Lind, Sheila Fisher, Toby C. Trujillo, Michael F. Wempe, Tyree H. Kiser
High incidence of under-treated atrial fibrillation: perspectives from an Asian Stroke Endovascular Thrombectomy Registry
Benjamin Yong-Qiang Tan, Aloysius Sheng-Ting Leow, Hock Luen Teoh, Anil Gopinathan, Cunli Yang, Prakash R. Paliwal, Vijay K. Sharma, Raymond Chee-Seong Seet, Bernard Poon-Lap Chan, Leonard Leong-Litt Yeo
Direct oral anticoagulants: a review on the current role and scope of reversal agents
Rahul Chaudhary, Tushar Sharma, Jalaj Garg, Ajaypaul Sukhi, Kevin Bliden, Udaya Tantry, Mohit Turagam, Dhanunjaya Lakkireddy, Paul Gurbel
Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center
Sweta Meet Patel, Tina Wang, Desire Lashalle Outler, Jennifer Elliott, Michael Knauss, Samuel K. Peasah, Mikhail Akbashev
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care
Markus Gulilat, Denise Keller, Bradley Linton, A. Demetri Pananos, Daniel Lizotte, George K. Dresser, Jeffrey Alfonsi, Rommel G. Tirona, Richard B. Kim, Ute I. Schwarz
Factors associated with women’s adherence to postpartum thromboprophylaxis
Amihai Rottenstreich, Adi Karlin, Yosef Kalish, Gabriel Levin, Misgav Rottenstreich
Congenital fibrinogen disorders with repeated thrombosis
Xiuli Zhang, Chuang Zhang, Baoheng Wang, Ningheng Chen, Gaihe Sun, Xueli Guo
Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project
Maria R. Bernstein, Libiny John, Susan Sciortino, Elise Arambages, Danielle Auletta, Alex C. Spyropoulos
Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more
Bernhard Wernly, Deepak L. Bhatt, Amin Polzin, Christian Jung
The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes
Leonard Naymagon, Douglas Tremblay, Thomas Schiano, John Mascarenhas
Initiation of a fixed- dose four- factor prothrombin complex concentrate protocol
Ajay Kumar Mishra, Kamal Kant Sahu, Ahmad Daniyal Siddiqui, Susan V. George
A case report of severe bleeding due to lupus anticoagulant hypoprothrombinemia syndrome
Elsa Meireles, Filipe Machado, Luís Teles, Anna Chumakova, Joana Sequeira, Ana Spínola